Avid Bioservices, Inc.
CDMO US
CDMO USAvid Bioservices, Inc.
United States CompositeCompany Description
- CEO
- Mr. Nicholas Stewart Green B.Sc., MBA
- Full Time Employees
- 365
- Sector
- Healthcare
- Industry
- Biotechnology
- Address
- 14191 Myford Road Tustin CA United States 92780
- IPO Date
- Apr 4, 1994
- Website
- www.avidbio.com
- Business
- Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.
Company News
Craig-Hallum Remains a Buy on Avid Bioservices (CDMO)
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
Analysts’ Top Healthcare Picks: Avid Bioservices (CDMO), LifeMD (LFMD)
Craig-Hallum Remains a Buy on Avid Bioservices (CDMO)
Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q
To Buy a Bank, You Have to Be a Bank
Avid Bioservices Inc (CDMO) Releases Preliminary Q3 Financial Results
RBC Capital Sticks to Its Buy Rating for Avid Bioservices (CDMO)
Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
Avid Bioservices Announces Proposed Private Placement of Convertible Notes
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024